117 related articles for article (PubMed ID: 28034736)
1. Cutaneous iontophoresis of μ-conotoxin CnIIIC-A potent Na
Del Río-Sancho S; Cros C; Coutaz B; Cuendet M; Kalia YN
Int J Pharm; 2017 Feb; 518(1-2):59-65. PubMed ID: 28034736
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
4. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
[TBL] [Abstract][Full Text] [Related]
5. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y; Zahui T; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewis(x) mimetic, in vitro.
Gratieri T; Wagner B; Kalaria D; Ernst B; Kalia YN
Exp Dermatol; 2012 Mar; 21(3):226-8. PubMed ID: 22379971
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Kalaria DR; Patel P; Patravale V; Kalia YN
Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
[TBL] [Abstract][Full Text] [Related]
9. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
Dubey S; Kalia YN
J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
[TBL] [Abstract][Full Text] [Related]
10. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.
Kalaria DR; Singhal M; Patravale V; Merino V; Kalia YN
Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356
[TBL] [Abstract][Full Text] [Related]
12. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
Dubey S; Perozzo R; Scapozza L; Kalia YN
Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive targeted iontophoretic delivery of cetuximab to skin.
Lapteva M; Sallam MA; Goyon A; Guillarme D; Veuthey JL; Kalia YN
Expert Opin Drug Deliv; 2020 Apr; 17(4):589-602. PubMed ID: 32067504
[No Abstract] [Full Text] [Related]
15. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis.
Kale M; Kipping T; Banga AK
Int J Pharm; 2020 Nov; 589():119853. PubMed ID: 32898633
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
17. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
[TBL] [Abstract][Full Text] [Related]
18. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue.
Dubey S; Perozzo R; Scapozza L; Kalia YN
Int J Pharm; 2020 Nov; 589():119913. PubMed ID: 32971174
[TBL] [Abstract][Full Text] [Related]
19. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
[TBL] [Abstract][Full Text] [Related]
20. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
